针对肝细胞癌的向治疗和采用T细胞免疫疗法中的CRISPR
Fahreddin Palaz1,2, Mehmet Ozsoz3, Ali Zarrinpar4,5
1Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Journal of hepatocellular carcinoma
|June 4, 2024
概括
基因编辑CRISPR通过修改细胞提供了治疗晚期肝癌 (HCC) 的新方法. 这项技术有望改善患者的治疗结果,克服当前治疗的局限性.
科学领域:
- 在瘤学瘤学.
- 基因编辑 基因编辑
- 免疫治疗是一种免疫疗法.
背景情况:
- 晚期肝细胞癌 (HCC) 尽管有目前的治疗方法,但结果不佳.
- 对于HCC管理,迫切需要新的治疗策略.
研究的目的:
- 审查CRISPR基因编辑技术在治疗HCC中的应用.
- 探索CRISPR在向癌细胞和工程免疫细胞中的作用,用于HCC治疗.
主要方法:
- 在HCC中对CRISPR应用的综合文献综述.
- 专注于体内向,CAR T细胞和TCR工程T细胞疗法.
- 分析与现有治疗方法和临床试验的潜在协同作用.
主要成果:
- 克里斯普技术可以对癌细胞和T细胞进行基因操纵,用于治疗HCC.
- 应用包括体内向和先进免疫疗法的开发.
- 目前正在进行的试验正在研究基于CRISPR的策略,以改善HCC的结果.
结论:
- 克里斯普尔基因编辑为先进的HCC治疗提供了一个有希望的前沿.
- 挑战和安全考虑对于临床翻译至关重要.
- 这项技术有可能彻底改变HCC治疗方法,改善患者的生存率.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


